Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis.
about
Protein glutathionylation in cardiovascular diseasesCardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopauseHydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truthPrelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivoRedox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Functional recovery of diabetic mouse hearts by glutaredoxin-1 gene therapy: role of Akt-FoxO-signaling network.Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice.Glutaredoxin-1 overexpression enhances neovascularization and diminishes ventricular remodeling in chronic myocardial infarction.Expression pattern of the thioredoxin system in human endothelial progenitor cells and endothelial cells under hypoxic injuryThioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome.Coronary artery endothelial transcriptome in vivo: identification of endoplasmic reticulum stress and enhanced reactive oxygen species by gene connectivity network analysis.Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary diseaseA comparison of genome-wide DNA methylation patterns between different vascular tissues from patients with coronary heart diseaseEndothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions.Epigenetic Regulatory Effect of Exercise on Glutathione Peroxidase 1 Expression in the Skeletal Muscle of Severely Dyslipidemic Mice.Lipid peroxidation and the levels of antioxidant enzymes in coronary artery disease.New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects.Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases.Redox-based regulation of signal transduction: principles, pitfalls, and promisesEndothelial Cell Redox Regulation of Ischemic Angiogenesis.Regulation of neovascularization by S-glutathionylation via the Wnt5a/sFlt-1 pathway.Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin.Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's DiseaseGlutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularizationLipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis.Cell stress proteins in atherothrombosisThe glutaredoxin/glutathione system modulates NF-kappaB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells.Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.Oxidized lipoprotein induces the macrophage ascorbate transporter (SVCT2): protection by intracellular ascorbate against oxidant stress and apoptosis.Thioredoxin-1 gene delivery induces heme oxygenase-1 mediated myocardial preservation after chronic infarction in hypertensive rats.Redox regulation of Ito remodeling in diabetic rat heart.Oxidative stress: Predictive marker for coronary artery disease.Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet.The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries.Nanoparticles in Medicine: A Focus on Vascular Oxidative Stress
P2860
Q27009841-E4C5035F-CB18-4B96-8A47-640AB1764804Q28513051-FB10BB4B-0A7D-4B09-B57B-E19832D18F02Q30457642-D57AD673-18FC-45DA-B12A-56ADCE74B412Q33589194-66194A09-C19F-4AFA-B21D-BEF843F7E678Q33649846-3CA2BDF5-220E-4826-BD00-8DD57E28674DQ33761211-27F2C923-18C2-4B5F-B970-DEBECF3A9C3EQ33778090-CA26EFA5-AE97-4D9B-9E7D-E2F1FF09059EQ34091379-AAE42EF6-8CAE-4FB1-97B2-252FC55A6AE9Q34241559-946266B7-53EB-49B3-B7E5-C3A18A9C9491Q34512564-8A08ADA3-2CF1-43D5-A427-C644A20BCCCCQ34731377-881D0F5A-6EB3-4305-BE17-4099C0AF7A62Q35048311-16F59B35-1B83-447D-AC75-92CE334C0D3FQ35125384-7820C0D2-F4AC-4B35-87CA-94D95BE3F15FQ35346952-37777DB7-6454-437C-BCF2-43394C486DB0Q35781399-C0C1A164-1805-43E5-8184-0E99E80D8327Q35968920-3E843513-7BD5-46DA-9B2A-A46F8822DF70Q36264369-53021865-E910-4A4A-9061-720C6941C2B8Q36553779-500DE70A-4476-429B-A40E-D44E36406013Q36733465-D2977104-9677-4298-A49A-B58B3007E586Q36756386-83E030B3-5581-496E-A1B8-2B6F09C6CDC3Q36984724-0808348F-88DC-49DD-A86C-AB767047B52AQ37069521-7AF4F949-0DB0-4E65-9346-A06011099946Q37165144-1DDAC37F-6C97-4CCD-ADBE-B4BBA99A55BBQ37262124-AEE3AA78-DD2D-42C7-B462-4539657FBC50Q37360483-4B46839A-FF67-40F8-B822-5DF54974B8CBQ37523363-26BFE5E0-93D3-4890-9BD7-F170C11B249BQ37653350-66EA3FFC-169C-4990-96D5-1D33E4AC846CQ37951442-62D299E1-11E5-4852-8E23-48263FC62947Q38026043-C826348D-50E5-4A64-BC77-E50D8DC9BC96Q39721318-BD15B30E-7E0B-48A2-873B-DBD84ED00016Q39869061-B18787DF-F27C-41DA-89E2-1F21093691D6Q39878030-635B531A-936C-49E9-BE79-CDAF3E15571CQ40009464-EA5EBCE4-E37D-4E9D-BB66-495F18592A0CQ42470417-E7AF70E2-1EE0-4129-8E68-232E426A6CD6Q43081749-CA77A116-F025-48AD-A995-6642FE45E4B8Q46269480-442BEA0D-91AD-46CD-8985-A1AFE423158DQ46968906-0B9BCF94-E98A-421B-8175-6CF8C4471804Q48256915-5BA4195D-4B6C-4324-8260-158EAB028842Q52881127-281F2C34-4784-43B8-A6EC-8FCE2E47BC2AQ57821326-2488B777-64CD-415F-84E7-A54370076776
P2860
Expression of glutaredoxin in human coronary arteries: its potential role in antioxidant protection against atherosclerosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Expression of glutaredoxin in ...... ction against atherosclerosis.
@en
Expression of glutaredoxin in ...... ction against atherosclerosis.
@nl
type
label
Expression of glutaredoxin in ...... ction against atherosclerosis.
@en
Expression of glutaredoxin in ...... ction against atherosclerosis.
@nl
prefLabel
Expression of glutaredoxin in ...... ction against atherosclerosis.
@en
Expression of glutaredoxin in ...... ction against atherosclerosis.
@nl
P2093
P356
P1476
Expression of glutaredoxin in ...... ction against atherosclerosis.
@en
P2093
Kawashima S
P304
P356
10.1161/HQ0901.095550
P407
P577
2001-09-01T00:00:00Z